Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prime Medicine Inc (NQ: PRME ) 5.140 -0.190 (-3.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,573,079 Open 5.330 Bid (Size) 5.100 (5) Ask (Size) 5.170 (60) Prev. Close 5.330 Today's Range 4.990 - 5.360 52wk Range 4.110 - 15.75 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Prime Medicine to Present at Upcoming Investor Conferences May 30, 2024 From Prime Medicine, Inc. Via GlobeNewswire If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names May 29, 2024 Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. Via InvestorPlace Exposures Product Safety Performance YTD -41.32% -41.32% 1 Month -20.68% -20.68% 3 Month -23.96% -23.96% 6 Month -41.32% -41.32% 1 Year -64.55% -64.55% More News Read More Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio May 25, 2024 Via The Motley Fool Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 May 17, 2024 Via InvestorPlace Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 Via InvestorPlace Recap: Prime Medicine Q4 Earnings March 01, 2024 Via Benzinga Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ May 13, 2024 From Prime Medicine, Inc. Via GlobeNewswire PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 May 10, 2024 Via InvestorPlace Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates May 10, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) May 08, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket May 02, 2024 Via Benzinga Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference May 01, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday April 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 29, 2024 Via InvestorPlace Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) April 29, 2024 From Prime Medicine, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 26, 2024 Via Benzinga Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings April 23, 2024 From Prime Medicine, Inc. Via GlobeNewswire 2 Magnificent Growth Stocks With Room to Run March 27, 2024 Via The Motley Fool Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging March 14, 2024 Via InvestorPlace Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? March 01, 2024 Via InvestorPlace Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates March 01, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine to Participate in Upcoming Investor Conferences February 28, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares February 20, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Pricing of Upsized Public Offering February 14, 2024 From Prime Medicine, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.